Figure 3.
Ex vivo cytokine responses following intranasal peptide, before and after skin grafting. HYAbDby peptide and peptide plus LPS intranasally treated mice at day 5. Three mice from each group of mice, given 3 × 100 μg HYAbDby with (A,C) or without (B,D) 3 μg LPS were killed and cervical lymph nodes taken for ELISPOT analysis. Panels A and B show the IFN-γ response in the presence of irradiated female splenocytes alone or pulsed with HYDbUty or HYAbDby peptide; panels C and D show the IL-2 response. PBS- and HYAbDby peptide–pretreated mice 8 and 21 days after skin grafting. Two groups of B6 females (8 mice/group) pretreated with 3 × 100 μg HYAbDby peptide or PBS intranasally were given grafts with syngeneic male skin 10 days later. Recipients were killed 8 (5 mice per group) and 21 (3 mice per group) days later, and cell suspensions from graft-draining lymph nodes, from PBS-treated (E,G,I,K) and peptide-treated mice (F,H,J,L), were tested by ELISPOT assay for IFN-γ (E,F,I,J) and IL-2 (G,H,K,L) production in response to irradiated female splenocytes alone or pulsed with HYDbUty or HYAbDby peptide. Results are expressed as spots/2 × 105 cells. Each symbol represents an individual mouse.